Increased Risk of Tourette Syndrome with Leukotriene Modifier Use in Children with Allergic Diseases and Asthma: A Nationwide Population-Based Study

• Ngā kaituhi matua: Min-Lan Tsai (Author), Hsiu-Chen Lin (Author), Chiung-Hui Yen (Author), Jung-Tzu Ku (Author), Shian-Ying Sung (Author), Hsi Chang (Author)
• Hōputu: Pukapuka
• I whakaputaina: MDPI AG, 2022-10-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

(1) Background: Cysteinyl leukotriene receptor antagonists (LTRAs), including montelukast and zafirlukast, are FDA-approved for treating pediatric asthma and allergic diseases. Tourette syndrome (TS), a common neuropsychiatric disorder in children, is associated with allergic diseases and asthma. In...